The National Health Insurance Service made a pre-announcement for the amendment of the detailed guidelines of the ‘Price-Volume Agreement.’

The Price-Volume Agreement, or PVA, is a system that discounts a drug’s price by up to 10% through negotiation between the pharmaceutical company and NHIS for products whose use volume had rapidly increased. The system was implemented to save NHI finances.

The current system has been in place since 2014 after the system was implemented in 2007, therefore the move for its improvement seems timely.

However, the NHIS and the pharmaceutical industry have mixed opinions on how to amend the system. This clash is most prominent in the mat